CLINICAL_TRIALS
trial_result
· 2022-01-24
Clinical Trial Update: Evaluation of the LipiFlow System With a New Activator [NA]
Summary
Clinical trial update for the LipiFlow System with a new activator in Meibomian Gland Dysfunction has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johnson & Johnson Surgical Vision, Inc. | Conditions: Meibomian Gland Dysfunction | NA | Status: COMPLETED | Results posted: 2022-01-24